BioMarin Pharmaceutical (NASDAQ:BMRN – Get Rating) is scheduled to be announcing its earnings results after the market closes on Monday, February 27th. Analysts expect the company to announce earnings of $0.38 per share for the quarter. Individual interested in registering for the company’s earnings conference call can do so using this link. BioMarin Pharmaceutical Stock […]
Allianz Asset Management GmbH lowered its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) by 100.0% during the 3rd quarter, Holdings Channel.com reports. The fund owned 49,454 shares of the biotechnology company’s stock after selling 170,815,053 shares during the quarter. Allianz Asset Management GmbH’s holdings in BioMarin Pharmaceutical were worth $4,191,000 as […]
Innovative MedTech company supported by US Capital Global Securities sees international expansion and continued success with its new medical imaging technology.